George Yancopoulos, Chairman of Regeneron Pharmaceuticals REGN, has filed 0 purchases and 48 sales on the open market. The latest trade was on 25/12/31.

GY

GY

George Yancopoulos

Bd. Co-Chair, President & CSO

Company

Regeneron Pharmaceuticals REGN

First filing

23/02/08

Trades

64 trades

Buys / sales

0 / 48

12-month net buying

No record

Last trade

25/12/31

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/05/15–24/05/16	24/05/17	100,000 sh37 trades	$974.30avg.	$97,430,272.46	−11.3%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/01/02	24/05/01	16,848 sh	$900.00	$15,163,200	−8.6%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/01/02	24/01/04	16,848 sh	$900.00	$15,163,200	−8.6%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	23/03/23	23/03/27	3,656 sh8 trades	$804.26avg.	$2,940,374.33	−1.8%
Regeneron PharmaceuticalsREGN	Open-market sale	23/02/06	23/02/08	13,189 sh	$800.08	$10,552,255.12	−6.2%